RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 59 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246,101 | +4.9% | 32,318 | -9.6% | 0.00% | – |
| Q2 2023 | $234,592 | -7.3% | 35,761 | -15.5% | 0.00% | – |
| Q1 2023 | $253,127 | +174.6% | 42,329 | +7.0% | 0.00% | – |
| Q4 2022 | $92,196 | -31.2% | 39,569 | -0.8% | 0.00% | – |
| Q3 2022 | $134,000 | +148.1% | 39,886 | +94.6% | 0.00% | – |
| Q2 2022 | $54,000 | +237.5% | 20,495 | +278.9% | 0.00% | – |
| Q1 2022 | $16,000 | -73.8% | 5,409 | -24.3% | 0.00% | – |
| Q4 2021 | $61,000 | +103.3% | 7,148 | +71.8% | 0.00% | – |
| Q3 2021 | $30,000 | -89.7% | 4,160 | -86.7% | 0.00% | – |
| Q2 2021 | $291,000 | – | 31,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |